Pulsed Radiofrequency Eases Nerve Pain by Targeting Key Pain Signaling Protein

Neuropathic pain—chronic pain caused by nerve damage—affects an estimated 7–10% of adults worldwide. It’s stubborn: common treatments like opioids or nerve blocks often fail, and many cause side effects like numbness or addiction. But a minimally invasive technique called pulsed radiofrequency (PRF) has emerged as a promising alternative. Unlike traditional radiofrequency, which burns nerves to stop pain, PRF uses short, low-heat electrical bursts that don’t damage tissue. Now, a 2019 study from Chinese researchers helps explain how PRF works—and why it could be a game-changer for nerve pain.

What Is PRF, and Why Does It Matter?

PRF was first developed in the 1990s as a “non-destructive” pain treatment. It delivers high-frequency electricity in 20-millisecond bursts (with 480-millisecond pauses) that keep tissue temperature below 42°C—cool enough to avoid nerve damage. Doctors already use PRF for conditions like trigeminal neuralgia (facial pain) and post-herpetic neuralgia (shingles-related pain), but until now, no one knew exactly how it eases neuropathic pain.

The P2X3 Receptor: A Key Player in Pain

The study focused on the P2X3 receptor—a protein found on sensory nerve cells that send pain signals from the body to the spinal cord and brain. When nerves are injured, they release a chemical called ATP, which binds to P2X3 receptors. This “turns on” the nerves, amplifying pain signals and leading to the constant, burning pain of neuropathic conditions. Previous research showed that blocking P2X3 receptors reduces pain in animals—but could PRF do the same by lowering P2X3 levels?

The Study: Testing PRF on Rats With Nerve Damage

To find out, researchers from Peking University Cancer Hospital and Beijing Tiantan Hospital used a common animal model of neuropathic pain: chronic constriction injury (CCI). They surgically compressed the sciatic nerve (a major nerve in the leg) of 36 rats to mimic human nerve damage. The rats were split into three groups:

Sham group: Nerves were exposed but not compressed (no pain).
CCI group: Nerves were compressed (to cause pain) but not treated with PRF.
PRF group: Nerves were compressed, then treated with PRF (42°C, 45V, 2 minutes) 14 days later.

They measured two key pain indicators:

Mechanical pain threshold: How much pressure (using tiny “Von Frey filaments”) the rats could tolerate on their injured paw before pulling away.
Thermal pain threshold: How long they could stand heat on their paw before withdrawing it.

Four weeks after PRF treatment, the team also analyzed P2X3 receptor levels in two critical parts of the pain pathway: the dorsal root ganglia (DRG) (clusters of nerve cells near the spine) and the spinal dorsal horn (where pain signals enter the spinal cord).

The Results: PRF Reduces Pain—and P2X3 Receptors

The findings were striking:

Pain relief lasted weeks: Untreated CCI rats pulled away from light pressure (just 3.62g) and heat (15.10 seconds). PRF-treated rats tolerated twice as much pressure (8.33g) and 10 seconds more heat (25.42s) by day 28.
P2X3 levels dropped: PRF reduced P2X3 receptor levels by 23–35% in the DRG and spinal dorsal horn compared to untreated CCI rats. Less P2X3 meant fewer pain signals reaching the brain.

What This Means for Nerve Pain Patients

The study’s lead authors—Miao Fu, Lan Meng, Hao Ren, and Fang Luo—say PRF works by downregulating P2X3 receptors on pain-sensing nerves. This is a big deal: it’s one of the first studies to link PRF’s pain-relieving effects to a specific molecular target.

For patients, the takeaway is hopeful: PRF offers long-lasting pain relief without damaging nerves. Clinical data backs this up: PRF has helped people with trigeminal neuralgia, occipital neuralgia (head/neck pain), and chronic inguinal neuralgia (groin pain) find relief for months.

Limits and Future Research

The study isn’t perfect. A single PRF session didn’t fully normalize P2X3 levels or pain thresholds—meaning multiple treatments might be needed. The researchers also note that more work is needed to confirm if PRF has the same effect in humans and if combining PRF with P2X3-blocking drugs could boost results.

The Bottom Line

Neuropathic pain is tough, but PRF is a promising tool—and this study explains why. By targeting the P2X3 receptor, PRF reduces pain signals at the source, offering a safe, long-lasting alternative to destructive therapies. For millions living with nerve pain, that’s a reason to hope.

Original study: “Pulsed radiofrequency inhibits expression of P2X3 receptors and alleviates neuropathic pain induced by chronic constriction injury in rats” by Miao Fu, Lan Meng, Hao Ren, and Fang Luo, published in the Chinese Medical Journal (2019). DOI: doi.org/10.1097/CM9.0000000000000302

Was this helpful?

0 / 0